[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370933-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370933-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","roles-of-kdm5-demethylases-in-therapeutic-resistance-of-cancers-review","Roles of KDM5 demethylases in therapeutic resistance of cancers - review","","Epigenetic modifications, especially histone H3 lysine 4 methylation (H3K4me2/3), regulate tissue homeostasis and shape cancer development, including growth, invasion, metastasis, and therapeutic resistance. The KDM5 demethylase family (KDM5A–KDM5D) mediates the demethylation of these marks and has been linked to resistance across chemotherapy, radiotherapy, immune evasion, and targeted therapies. This review summarizes molecular mechanisms, key targets, and interactions of KDM5 demethylases within the tumor microenvironment, then highlights emerging therapeutic strategies to overcome resistance by targeting KDM5 demethylases, supporting improved efficacy and long-term patient outcomes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/roles-of-kdm5-demethylases-in-therapeutic-resistance-of-cancers-review/370933/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/roles-of-kdm5-demethylases-in-therapeutic-resistance-of-cancers-review/370933.png","ImageObject",300,407,{"name":42,"@type":43},"Ben ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What are KDM5 demethylases and why are they important in cancer?","Question",{"text":63,"@type":64},"KDM5 demethylases (KDM5A–KDM5D) remove methyl groups from histone H3 lysine 4 methylation (H3K4me2/3). They influence cancer progression and therapy outcomes by regulating epigenetic states.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do KDM5 demethylases contribute to therapeutic resistance?",{"text":68,"@type":64},"They are associated with resistance mechanisms spanning chemoresistance, radioresistance, immune evasion, and resistance to targeted therapies. The review explains these pathways through molecular targets and interactions.",{"name":70,"@type":61,"acceptedAnswer":71},"What therapeutic strategies does the review discuss to overcome resistance?",{"text":72,"@type":64},"The review discusses emerging approaches aimed at improving treatment response by targeting KDM5 demethylases, with the goal of counteracting therapy resistance and enhancing long-term patient survival and quality of life.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370933,1790252081,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336478951081,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Chen et al. Epigenetics & Chromatin (2025) 18:61 [https://doi.org/10.1186/s13072-025-00624-3](https://doi.org/10.1186/s13072-025-00624-3)  \nEpigenetics & Chromatin  \nREVIEW Open Access  \nRoles of KDM5 demethylases in therapeutic resistance of cancers  \nXiaobo Chen 1,2†, Manjun Chen2†, Xingkun Gu2†, Qinghua Zhou 1, Yunping Zhao2, Yanlong Yang2, Hongwei Zhang2 and Xudong Yang 1,2*  \nAbstract  \nEpigenetic modifications, including the regulation of histone H3 lysine 4 methylation (H3K4me2/3), play critical roles in maintaining normal tissue homeostasis and influencing the progression of cancer, including growth, invasion, metastasis, and therapeutic resistance. The demethylation of H3K4me2/3 is orchestrated by the KDM5 demethylase family, comprising KDM5A, KDM5B, KDM5C, and KDM5D. Recent studies have highlighted the pivotal role of KDM5 demethylases in mediating resistance to cancer therapies, encompassing chemoresistance, radioresistance, immune evasion, and targeted therapy resistance. This review provides a comprehensive overview of the regulatory mechanisms by which KDM5 demethylases contribute to these resistance pathways, with a focus on their molecular targets and interactions within the tumor microenvironment. Furthermore, we discuss emerging therapeutic strategies aimed at overcoming treatment resistance by targeting KDM5 demethylases. These insights provide a foundation for the development of innovative therapeutic interventions to enhance the efficacy of existing cancer treatments, offering a transformative approach to improving long-term patient survival and quality of life.  \nKeywords KDM5 demethylases, Histone methylation, Therapeutic resistance, Immune evasion, Cancer  \nIntroduction  \nConservative treatment for advanced cancer and adjuvant therapy before or after surgery including chemotherapy, radiotherapy, targeted therapy, and immunotherapy holds great promise in improving quality and length of patient life. Resistance appeared almost inevitably in the processes of these treatments, which  \n† Xiaobo, Chen, Manjun Chen and Xingkun Gu contributed equally to this work.  \n*Correspondence:  \nXudong Yang  \n[yxdyndl@163.com](yxdyndl@163.com)  \n1Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Sichuan 610065 Chengdu, P. R. China 2Department of Thoracic Surgery, The First Affiliated Hospital of Kunming Medical University, No. 295 Xichang Road, Wuhua District,  \nKunming 650032 Yunnan, P. R. China  \nusually lead to treatment failure ultimately [1]. Resistance mechanism such as secondary mutation in drug target, bypass activation, epithelial to mesenchymal transition (EMT), increased drug efflux, and inhibition of apoptosis have been documented extensively in numerous studies [2–6]. Over the years, with the revelation of increasing knowledges on epigenetic modifications in cancer cell proliferation, differentiation, metabolism, metastasis, and microenvironment [7], a growing number of researchers have been demonstrating the critical roles of epigenetic modifications in cancer therapy resistance regulation [8]. Epigenetic modifications mainly comprise six regulatory processes including DNA methylation, histone post-translational modifications (PTMs) such as methylation, acetylation, phosphorylation, ubiquitylation, and SUMOylation, ATP-dependent chromatin remodelling complexes, non-coding RNAs, nuclear dynamics and  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or oth","cbCaiiwZpg6J4tn0","https://ap.wps.com/l/cbCaiiwZpg6J4tn0","pdf",3542910,17,"English","# Introduction\n## Epigenetic modifications and cancer therapy resistance\n# KDM5 demethylases and resistance mechanisms\n## Chemoresistance and radioresistance\n## Immune evasion and targeted therapy resistance\n# Tumor microenvironment interactions\n# Therapeutic strategies targeting KDM5 demethylases\n# Conclusion","[{\"question\":\"What are KDM5 demethylases and why are they important in cancer?\",\"answer\":\"KDM5 demethylases (KDM5A–KDM5D) remove methyl groups from histone H3 lysine 4 methylation (H3K4me2/3). They influence cancer progression and therapy outcomes by regulating epigenetic states.\"},{\"question\":\"How do KDM5 demethylases contribute to therapeutic resistance?\",\"answer\":\"They are associated with resistance mechanisms spanning chemoresistance, radioresistance, immune evasion, and resistance to targeted therapies. The review explains these pathways through molecular targets and interactions.\"},{\"question\":\"What therapeutic strategies does the review discuss to overcome resistance?\",\"answer\":\"The review discusses emerging approaches aimed at improving treatment response by targeting KDM5 demethylases, with the goal of counteracting therapy resistance and enhancing long-term patient survival and quality of life.\"}]","Roles of KDM5 demethylases in therapeutic resistance of cancers - review | PDF",1790190859,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4856a41f65cc7d192a92093bcc1419af.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/950eb801a934c2de193edbd66c2da6eb.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c911b06c7370f4079a8fdb8ea5bcac8b.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3eed01558063c005287ad3f851897683.webp",980,1306]